All Comments by Richard C. Mohs
Go to another page:
- 1
- 2
- Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
- Delirium accelerates cognitive decline in Alzheimer disease.
- Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
- A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
- Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
- Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
- PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.
- Variations in the neuropathology of familial Alzheimer's disease.
- Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.
- Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.
- Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
- Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
- Prevalence and implications of psychopathological non-cognitive symptoms in dementia.
- Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?